Skip to main content

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

T2CogVR - Structural and functional brain changes as a proxy for Virtual Reality cognitive training efficacy in Type 2 Diabetes Mellitus elderly patients

IP: Rafael Simó Canonge
Collaborators: -
Funding agency: Fundació "La Caixa"
Funding: 92327.22
Reference: SR20-00730
Duration: 01/02/2021 - 30/09/2024

Bloqueo intraocular de la hemopexina: una nueva estrategia para tratar el edema macular diabético

IP: Rafael Simó Canonge
Collaborators: Hugo Ramos Abellan, Patricia Bogdanov Baruj
Funding agency: Instituto de Salud Carlos III
Funding: 78100
Reference: DTS19/00171
Duration: 01/01/2020 - 31/12/2021

Incidència de complicacions de l'accés venós perifèric en la població diabètica tipus 2. Anàlisi dels factors de risc i estudi comparatiu de dos dispositius perifèrics.

IP: Rafael Simó Canonge
Collaborators: Marc Rivas Agudo, Miriam Izquierdo Sans
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 73343.84
Reference: SLT008/18/00104
Duration: 01/07/2019 - 20/03/2021

Unraveling the retinal and brain mediators of diabetes-induced neurodegeneration

IP: Rafael Simó Canonge
Collaborators: Santiago Ramon y Cajal Agüeras, Joan Montaner Villalonga, Lorena Ramos Pérez, Hugo Ramos Abellan, Patricia Bogdanov Baruj
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 242000
Reference: PID2019-104225RB-I00
Duration: 01/06/2020 - 31/05/2023

Ministerio de Ciencia

Related news

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

Related professionals

Jorge Serra Pueyo

Jorge Serra Pueyo

Main researcher
Physiology and Pathophysiology of the Digestive Tract
Read more
Jorge Pamias Romero

Jorge Pamias Romero

New Technologies and Craniofacial Microsurgery
Read more
Olga Luengo Sanchez

Olga Luengo Sanchez

Systemic Diseases
Read more
Anna Salo Rovira

Anna Salo Rovira

Research technician
Childhood Cancer and Blood Disorders
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.